We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lillie Named New Acting Director of FDA's Drug Safety Office
Lillie Named New Acting Director of FDA's Drug Safety Office
February 4, 2005
The FDA announced Jan. 27 that Ralph Lillie has taken over as acting director of the FDA’s Office of Drug Safety (ODS).